# FDA recall D-1250-2020

> **Lupin Pharmaceuticals Inc.** · Class II · drug recall initiated 2020-04-20.

## Product

Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, India. NDC 68180-0981-03

## Reason for recall

Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.

## Distribution

Product was distributed Nationwide in the United States.

## Key facts

- **Recall number:** D-1250-2020
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-04-20
- **Report date:** 2020-04-29
- **Termination date:** 2021-06-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1250-2020

## Citation

> AI Analytics. FDA recall D-1250-2020. Retrieved 2026-06-14 from https://api.ai-analytics.org/recall/D-1250-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*